- Home
- CYCC vs ACON Comparison
CYCC vs ACON Comparison
Compare CYCC & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- ACON
- Stock Information
- Founded
- CYCC 1992
- ACON 2008
- Country
- CYCC United States
- ACON United States
- Employees
- CYCC N/A
- ACON N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- CYCC Health Care
- ACON Technology
- Exchange
- CYCC Nasdaq
- ACON Nasdaq
- Market Cap
- CYCC 1.8M
- ACON 1.7M
- IPO Year
- CYCC N/A
- ACON 2022
- Fundamental
- Price
- CYCC $0.37
- ACON $0.17
- Analyst Decision
- CYCC Buy
- ACON Strong Buy
- Analyst Count
- CYCC 2
- ACON 1
- Target Price
- CYCC $11.00
- ACON $1.50
- AVG Volume (30 Days)
- CYCC 3.7M
- ACON 748.9K
- Earning Date
- CYCC 11-12-2024
- ACON 11-14-2024
- Dividend Yield
- CYCC N/A
- ACON N/A
- EPS Growth
- CYCC N/A
- ACON N/A
- EPS
- CYCC N/A
- ACON N/A
- Revenue
- CYCC $74,000.00
- ACON $49,289.00
- Revenue This Year
- CYCC N/A
- ACON N/A
- Revenue Next Year
- CYCC $16.28
- ACON $256.16
- P/E Ratio
- CYCC N/A
- ACON N/A
- Revenue Growth
- CYCC N/A
- ACON N/A
- 52 Week Low
- CYCC $0.35
- ACON $0.16
- 52 Week High
- CYCC $6.00
- ACON $7.39
- Technical
- Relative Strength Index (RSI)
- CYCC 29.98
- ACON 41.09
- Support Level
- CYCC $0.35
- ACON $0.16
- Resistance Level
- CYCC $0.52
- ACON $0.21
- Average True Range (ATR)
- CYCC 0.07
- ACON 0.02
- MACD
- CYCC -0.01
- ACON -0.00
- Stochastic Oscillator
- CYCC 3.94
- ACON 10.42
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.